المؤلفون: Xintong He, Leslie Koerner, Daina B. Esposito, Laura Wallace, Marc Miravitlles, Jennifer K Quint, Jukka Montonen, Alberto de la Hoz

المساهمون: Institut Català de la Salut, [Quint JK] National Heart and Lung Institute, Imperial College London, London, UK. [Montonen J, Wallace L] Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany. [Esposito DB, He X, Koerner L] Department of Safety and Epidemiology, HealthCore, Inc, Watertown, MA, USA. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Advances in Therapy

مصطلحات موضوعية: 030213 general clinical medicine, Exacerbation, Organic Chemicals::Aza Compounds::Azabicyclo Compounds::Tropanes::Scopolamine Derivatives::Tiotropium Bromide [CHEMICALS AND DRUGS], Pulmons - Malalties obstructives - Tractament, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Maintenance therapy, Adrenal Cortex Hormones, Pharmacology (medical), Farmacologia respiratòria, Original Research, COPD, Chronic obstructive pulmonary disease, Olodaterol, Hazard ratio, General Medicine, Bronchodilator Agents, enfermedades respiratorias::enfermedades pulmonares::enfermedades pulmonares obstructivas::enfermedad pulmonar obstructiva crónica [ENFERMEDADES], Treatment Outcome, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Female, hormones, hormone substitutes, and hormone antagonists, medicine.medical_specialty, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Muscarinic Antagonists, Lower risk, Database, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Corticosteroids, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, compuestos orgánicos::compuestos aza::compuestos azabicíclicos::tropanos::derivados de escopolamina::bromuro de tiotropio [COMPUESTOS QUÍMICOS Y DROGAS], Aged, Asthma, Respiratory Tract Diseases::Lung Diseases::Lung Diseases, Obstructive::Pulmonary Disease, Chronic Obstructive [DISEASES], business.industry, Tiotropium, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Confidence interval, Benzoxazines, respiratory tract diseases, chemistry, Avaluació de resultats (Assistència sanitària), business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3446c3ad53e6c49a71f8449ed192704Test
https://doi.org/10.1007/s12325-021-01646-5Test

المؤلفون: Aki Shiozawa, J.R. Earla, Carol R. Schermer, Rajender R. Aparasu, Daniel B. Ng, S.D. Sura

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, 030213 general clinical medicine, medicine.medical_specialty, Pyrrolidines, medicine.drug_class, Urology, Antimuscarinic, Muscarinic Antagonists, Medicare, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Anticholinergic, Humans, Pharmacology (medical), Oxybutynin, Aged, Benzofurans, Proportional Hazards Models, Retrospective Studies, Original Research, Aged, 80 and over, Solifenacin, Antimuscarinic Agent, Urinary Bladder, Overactive, Nursing home, business.industry, Overactive bladder, Retrospective cohort study, General Medicine, medicine.disease, United States, Nursing Homes, Discontinuation, Withholding Treatment, Adherence, 030220 oncology & carcinogenesis, Mandelic Acids, Urological Agents, Female, Tolterodine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f04538eefb620e454bbf3ba577f9adTest
https://doi.org/10.1007/s12325-020-01412-zTest

المؤلفون: Pardis Lakzadeh, Karissa Johnston, David Walker

المصدر: Advances in Therapy

مصطلحات موضوعية: Quality of life, Male, 030213 general clinical medicine, medicine.medical_specialty, Urology, Urinary incontinence, MEDLINE, Review, Muscarinic Antagonists, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, medicine, Humans, Pharmacology (medical), Patient Reported Outcome Measures, Botulinum Toxins, Type A, Intensive care medicine, Urinary Bladder, Overactive, business.industry, Overactive bladder, General Medicine, Middle Aged, medicine.disease, Patient reported outcome, humanities, female genital diseases and pregnancy complications, Clinical trial, Thiazoles, Treatment Outcome, Systematic review, 030220 oncology & carcinogenesis, Urological Agents, Acetanilides, Female, Patient-reported outcome, Observational study, Mirabegron, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ba9ac35fa70a44acca935f88b11f3fTest
https://doi.org/10.1007/s12325-019-0880-8Test

المؤلفون: Hajime Yoshisue, Rahul Lad, Chin Kook Rhee

المصدر: Advances in Therapy

مصطلحات موضوعية: 030213 general clinical medicine, Quinuclidines, Formoterol/aclidinium, Review, Quinolones, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Formoterol Fumarate, Pharmacology (medical), COPD, biology, Chronic obstructive pulmonary disease, Olodaterol, Fixed-dose combination, General Medicine, Lama, Bronchodilator Agents, Drug Combinations, Treatment Outcome, 030220 oncology & carcinogenesis, Indans, Long-acting β-agonists, Vilanterol, hormones, hormone substitutes, and hormone antagonists, medicine.drug, medicine.medical_specialty, Asia, Muscarinic Antagonists, Chlorobenzenes, 03 medical and health sciences, Asian People, Olodaterol/tiotropium, Administration, Inhalation, medicine, Humans, Tiotropium Bromide, Intensive care medicine, Adrenergic beta-2 Receptor Agonists, Indacaterol/glycopyrronium, Benzyl Alcohols, business.industry, Vilanterol/umeclidinium, medicine.disease, biology.organism_classification, Glycopyrrolate, Benzoxazines, Clinical trial, chemistry, Indacaterol, Formoterol, Long-acting muscarinic antagonists, business, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1247b8ba0a97926d975bfccb6199997fTest
https://pubmed.ncbi.nlm.nih.gov/30742242Test

المؤلفون: David A. Lipson, Noushin Brealey, Chang-Qing Zhu, Ruby Birk

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, 030213 general clinical medicine, Vital capacity, Quinuclidines, Single-inhaler triple therapy, Time Factors, Long-acting β2-agonist, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Inhaled corticosteroid, Forced Expiratory Volume, Pharmacology (medical), Budesonide, Original Research, COPD, medicine.diagnostic_test, Chronic obstructive pulmonary disease, General Medicine, Middle Aged, Serial FEV1, Fluticasone-Salmeterol Drug Combination, Bronchodilator Agents, 030220 oncology & carcinogenesis, Female, Vilanterol, medicine.drug, Spirometry, medicine.medical_specialty, Chlorobenzenes, Fluticasone propionate, 03 medical and health sciences, FEV1/FVC ratio, Double-Blind Method, Internal medicine, Administration, Inhalation, medicine, Humans, Benzyl Alcohols, Aged, business.industry, medicine.disease, Lung function, respiratory tract diseases, Androstadienes, Long-acting muscarinic antagonist, chemistry, Budesonide/formoterol, Formoterol, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988b40c1577d5911e21431132dd47ceaTest
https://pubmed.ncbi.nlm.nih.gov/33011864Test

المؤلفون: Wenqiong Xue, Dave Singh, Gary T. Ferguson, Alberto de la Hoz, Roland Buhl

المصدر: Advances in therapy. 37(10)

مصطلحات موضوعية: 030213 general clinical medicine, medicine.medical_specialty, medicine.drug_class, Muscarinic Antagonists, law.invention, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Maintenance therapy, Randomized controlled trial, law, Adrenal Cortex Hormones, Bronchodilator, Internal medicine, Forced Expiratory Volume, Post-hoc analysis, Medicine, Humans, Pharmacology (medical), Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, COPD, business.industry, Minimal clinically important difference, Olodaterol, General Medicine, medicine.disease, humanities, Confidence interval, respiratory tract diseases, Benzoxazines, Bronchodilator Agents, Drug Combinations, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, business, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f339a0aa98aeaa107523bef4fe3d52aTest
https://pubmed.ncbi.nlm.nih.gov/32671684Test

المؤلفون: John H. Riley, Ian Naya, Neil Barnes, Lee Tombs, Ana R. Sousa, Bernardino Alcázar Navarrete, Sadhana Patel, Gregory J. Feldman, David A. Lipson, Chris Compton

المساهمون: [Feldman, Gregory J.] S Carolina Pharmaceut Res, Spartanburg, SC 29303 USA, [Sousa, Ana R.] GlaxoSmithKline, Resp Res & Dev, Stockley Pk West, Uxbridge, Middx, England, [Lipson, David A.] GlaxoSmithKline, Resp Res & Dev, King Of Prussia, PA USA, [Lipson, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA, [Tombs, Lee] Precise Approach Ltd, Birmingham, W Midlands, England, [Barnes, Neil] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Patel, Sadhana] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Compton, Chris] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Riley, John H.] GlaxoSmithKline, GlaxoSmithKline Med Res Ctr, Resp Therapy Area Unit, Stevenage, Herts, England, [Naya, Ian] GlaxoSmithKline, Resp Med, Brentford, Middx, England, [Alcazar Navarrete, Bernardino] Hosp Alta Resoluc Loja, Neumol, Granada, Spain, GlaxoSmithKline

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Quinuclidines, Respimat, Long-acting β2-agonist, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Forced Expiratory Volume, Medicine, Pharmacology (medical), Vilanterol, 030212 general & internal medicine, Original Research, education.field_of_study, COPD, Cross-Over Studies, Olodaterol, LAMA, Double-blind, General Medicine, Middle Aged, Dry-powder inhaler, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Anesthesia, Combination, Long-acting beta 2-agonist, Female, Bronchodilation, Safety, Moderate, Population, LABA, Chlorobenzenes, 03 medical and health sciences, Bronchodilators, Double-Blind Method, Administration, Inhalation, Humans, Umeclidinium, Tiotropium Bromide, education, Benzyl Alcohols, Dynamic hyperinflation, Aged, business.industry, Nebulizers and Vaporizers, Tiotropium, medicine.disease, Confidence interval, Benzoxazines, Long-acting muscarinic antagonist, 030228 respiratory system, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa4d2adec229bf9ad2d05d732898175Test
https://doi.org/10.1007/s12325-017-0626-4Test

المؤلفون: Claus Vogelmeier, Dave Singh, Marc Miravitlles

المصدر: Advances in Therapy

مصطلحات موضوعية: medicine.medical_specialty, Dual bronchodilator, medicine.drug_class, Concordance, LABA, Muscarinic Antagonists, Review, Disease, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Bronchodilator, medicine, Humans, COPD, Pharmacology (medical), 030212 general & internal medicine, Intensive care medicine, Adrenergic beta-2 Receptor Agonists, Depression (differential diagnoses), Medicine(all), biology, business.industry, LAMA, General Medicine, Lama, biology.organism_classification, medicine.disease, Bronchodilator Agents, respiratory tract diseases, Aclidinium/formoterol, 030228 respiratory system, Quality of Life, Respiratory, Physical therapy, Anxiety, Symptom Assessment, Erratum, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05cd91b54f51e1eb5b29f830f3b111eTest
https://doi.org/10.1007/s12325-016-0459-6Test

المؤلفون: Susan Bell, Peter M.A. Calverley, Jens M. Hohlfeld, Michael Könen-Bergmann, Frank Richard

المساهمون: Publica

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Respimat, Pulmonology, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Maintenance therapy, Bronchodilator, Forced Expiratory Volume, Once-daily, Pharmacology (medical), 030212 general & internal medicine, Original Research, dose-response, Medicine(all), COPD, medicine.diagnostic_test, General Medicine, Tiotropium bromide, Middle Aged, humanities, Bronchodilator Agents, Treatment Outcome, Anesthesia, Female, Drug Monitoring, medicine.drug, Spirometry, Efficacy, medicine.drug_class, Chronic obstructive pulmonary disease (COPD), Muscarinic Antagonists, chronic obstructive pulmonary disease, 03 medical and health sciences, Administration, Inhalation, medicine, Humans, Tiotropium Bromide, Tiotropium Respimat® SMI, Aged, Dose-Response Relationship, Drug, business.industry, Inhaler, Respimat®, Tiotropium, medicine.disease, Lung function, respiratory tract diseases, Long-acting muscarinic antagonist, 030228 respiratory system, Dose–response, business, human activities

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078d5b4d7cf0bb85c675938c201aadc0Test